Common Variants of Apolipoprotein E and Cholesteryl Ester Transport Protein Genes in Male Patients With Coronary Heart Disease and Variable Body Mass Index
Restricted accessResearch articleFirst published online February, 2015
Common Variants of Apolipoprotein E and Cholesteryl Ester Transport Protein Genes in Male Patients With Coronary Heart Disease and Variable Body Mass Index
Plasma lipids are major risk factors for coronary heart disease (CHD). Cholesteryl ester transfer protein (CETP) and apolipoprotein (apo) E genes are involved in lipoprotein metabolism, thus affecting plasma lipid and lipoproteins levels. Furthermore, such polymorphisms have been associated with susceptibility to CHD and obesity. We evaluated the influence of the gene polymorphisms of CETP TaqIB (B1, B2) and I405V (V, I) and apo E (∊2,∊3,∊4) on lipid levels, according to body mass index (BMI) in Greek men with CHD. The TaqIB (B1, B2) polymorphism affected plasma low-density lipoprotein cholesterol levels in overweight men with CHD, whereas the I405V (V, I) polymorphism affected triglyceride concentrations in normal weight men. No correlation was found between BMI and apo E polymorphisms. Large prospective studies are required to investigate the relationships of CETP and apo E polymorphisms with lipids, BMI, and CHD susceptibility.
WhayneTFJr. Assessment of low-density lipoprotein targets. Angiology. 2013;64(6):411–416.
2.
Otocka-KmiecikAMikhailidisDPNichollsSJDavidsonMRyszJBanachM. Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease?Prog Lipid Res. 2012;51(4):314–324.
3.
AthyrosVGKatsikiNKaragiannisAMikhailidisDP. Should raising high-density lipoprotein cholesterol be a matter of debate?J Cardiovasc Med (Hagerstown). 2012;13(4):254–259.
4.
WierzbickiASClarkeREViljoenAMikhailidisDP. Triglycerides: a case for treatment?Curr Opin Cardiol. 2012;27(4):398–404.
5.
NikolicDKatsikiNMontaltoGIsenovicERMikhailidisDPRizzoM. Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches. Nutrients. 2013;5(3):928–948.
6.
MikhailidisDPElisafMRizzoM. “European panel on low density lipoprotein (LDL) subclasses”: a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. Curr Vasc Pharmacol. 2011;9(5):533–571.
7.
MikhailidisDPElisafMRizzoM. “European panel on low density lipoprotein (LDL) subclasses”: a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary. Curr Vasc Pharmacol. 2011;9(5):531–532.
8.
KolovouGDMikhailidisDPKovarJ. Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Curr Vasc Pharmacol. 2011;9(3):258–270.
9.
KolovouGDMikhailidisDPNordestgaardBGBilianouHPanotopoulosG. Definition of postprandial lipaemia. Curr Vasc Pharmacol. 2011;9(3):292–301.
10.
MihasCKolovouGDMikhailidisDP. Diagnostic value of postprandial triglyceride testing in healthy subjects: a meta-analysis. Curr Vasc Pharmacol. 2011;9(3):271–280.
11.
FreemanDJSamaniNJWilsonV. A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland coronary prevention study. Eur Heart J. 2003;24(20):1833–1842.
12.
KolovouGYiannakourisNHatzivassiliouM. Association of apolipoprotein E polymorphism with myocardial infarction in Greek patients with coronary artery disease. Curr Med Res Opin. 2002;18(3):118–124.
13.
KolovouGVasiliadisIKolovouV. The role of common variants of the cholesteryl ester transfer protein gene in left main coronary artery disease. Lipids Health Dis. 2011;10:156.
14.
TakeuchiFIsonoMKatsuyaT. Association of genetic variants influencing lipid levels with coronary artery disease in Japanese individuals. PLoS One. 2012;7(9):e46385.
15.
DoHQNazihHLucG. Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I: A-II concentrations: the prospective epidemiological study of myocardial infarction study. Metabolism. 2009;58(3):283–289.
16.
KolovouGKolovouVMihasC. Cholesteryl ester transfer protein and ATP-binding cassette transporter A1 genotype alter the atorvastatin and simvastatin efficacy: time for genotype-guided therapy?Angiology. 2013;64(4):266–272.
17.
KolovouGMihasCAnagnostopoulouK. Cholesteryl ester transfer protein gene and effectiveness of lipid lowering of atorvastatin. Open Cardiovasc Med J. 2010;4:297–301.
18.
FujiokaSMatsuzawaYTokunagaKTaruiS. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism. 1987;36(1):54–59.
19.
SrivastavaNAchyutBRPrakashJAgarwalCGPantDCMittalB. Association of cholesteryl ester transfer protein (TaqIB) and apolipoprotein E (HhaI) gene variants with obesity. Mol Cell Biochem. 2008;314(1-2):171–177.
20.
Terán-GarcíaMDesprésJPTremblayABouchardC. Effects of cholesterol ester transfer protein (CETP) gene on adiposity in response to long-term overfeeding. Atherosclerosis. 2008;196(1):455–460.
21.
FumeronFBetoulleDLucG. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest. 1995;96(3):1664–1671.
22.
GudnasonVKakkoSNicaudV. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group. Eur J Clin Invest. 1999;29(2):116–128.
23.
PadmajaNKumarRMBalachanderJAdithanC. Cholesteryl ester transfer protein TaqIB, -629C>A and I405 V polymorphisms and risk of coronary heart disease in an Indian population. Clin Chim Acta. 2009;402(1-2):139–145.
24.
OrdovasJMCupplesLACorellaD. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol. 2000;20(5):1323–1329.
25.
ThompsonADi AngelantonioESarwarN. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA. 2008;299(23):2777–2788.
26.
GhatrehsamaniKDarabiMRahbaniMHashemzadeh ChaleshtoryMFarrokhiENooriM. Combined hepatic lipase -514C/T and cholesteryl ester transfer protein I405 V polymorphisms are associated with the risk of coronary artery disease. Genet Test Mol Biomarkers. 2009;13(6):809–815.
27.
HuangYWuYLiuR. Differential effect of ATP binding cassette transporter A1 R219 K and cholesteryl ester transfer protein TaqIB genotypes on HDL-C levels in overweight/obese and non-obese Chinese subjects. Acta Cardiol. 2011;66(2):231–237.
28.
KuivenhovenJAde KnijffPBoerJM. Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels. Arterioscler Thromb Vasc Biol. 1997;17(3):560–568.
29.
FreemanDJPackardCJShepherdJGaffneyD. Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer protein activity. Clin Sci. 1990;79(6):575–581.
30.
HannukselaMLLiinamaaMJKesäniemiYASavolainenMJ. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis. 1994;110(1):35–44.
31.
PachockaLMWłodarczykMNowickaGKłosiewicz-LatoszekLWolańskaDStolarskaI. CETP gene TaqIB polymorphism and plasma lipids in patients with overweight and obesity. Rocz Panstw Zakl Hig. 2012;63(2):149–154.
32.
MitchellRJEarlLWilliamsJBisucciTGasiamisH. Polymorphisms of the gene coding for the cholesteryl ester transfer protein and plasma lipid levels in Italian and Greek migrants to Australia. Hum Biol. 1994;66(1):13–25.
33.
TenkanenHKoskinenPKontulaK. Polymorphisms of the gene encoding for cholesterol ester transfer protein and serum lipoprotein levels in subjects with and without coronary heart disease. Hum Genet. 1991;87(5):574–578.
34.
BruceCSharpDSTallAR. Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia. J Lipid Res. 1998;39(5):1071–1078.
35.
IsaacsASayed-TabatabaeiFAHofmanA. The cholesteryl ester transfer protein I405 V polymorphism is associated with increased high-density lipoprotein levels and decreased risk of myocardial infarction: the Rotterdam Study. Cardiovasc Prev Rehabil. 2007;14(3):419–421.
36.
Skoglund-AnderssonCEhrenborgEFisherRMOlivecronaGHamstenAKarpeF. Influence of common variants in the CETP, LPL, HL and APO E genes on LDL heterogeneity in healthy, middle-aged men. Atherosclerosis. 2003;167(2):311–317.
37.
RumpPMensinkRPHornstraG. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children. Nutr Metab Cardiovasc Dis. 2002;12(6):317–324.
38.
TalmudDrenos FShahS. Gene-centric association signals for lipids and apolipoproteins identified via the Human CVD BeadChip. Am J Hum Genet. 2009;85(5):628–642.
39.
KolovouGStamatelatouMAnagnostopoulouK. Cholesteryl ester transfer protein gene polymorphisms and longevity syndrome. Open Cardiovasc Med J. 201029;4:14–19.
40.
KolovouGDAnagnostopoulouKKKostakouP. Apolipoprotein E gene polymorphism and obesity status in middle-aged men with coronary heart disease. In Vivo. 2009;23(1):33–39.
